Fab I inhibitors

US6730684B1 · kind B1 · utility

Assignee

• Affinium Pharmaceuticals, Inc. · CA

Inventors

• William Henry Miller · Collegeville, US
• Kenneth A. Newlander · West Chester, US
• Mark A. Seefeld · Collegeville, US
• Irene N. Uzinskas · Villanova, US

Key dates

• Filing date: Apr 3, 2002
• Grant date: May 4, 2004
• Expiry date: Apr 3, 2022

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D231/56
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Compounds of formula (I) and (II) are disclosed wherein, R1, R2, R3, R4, X, A, B, D and Q are as disclosed in the specification, and the compounds are FabI inhibitors useful in the treatment of bacterial infections.